Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00198822 · ClinicalTrials.gov registry record · Phase 3
Impact of Maternal Vitamin A or Beta-Carotene Supplementation on Maternal and Infant Mortality in Bangladesh
A Phase 3 study, sponsored by Johns Hopkins Bloomberg School of Public Health.
- Completed
- Registry status
- Phase 3
- Development phase
- 59,666
- Enrollment target
NCT00198822: Completed Phase 3 study, sponsored by Johns Hopkins Bloomberg School of Public Health.
NCT00198822 is a Phase 3 study that has completed, run by Johns Hopkins Bloomberg School of Public Health. The registered enrollment target is 59,666 participants, above the 768-participant average among 15,282 other Phase 3 trials with a reported enrollment target (7669% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00198822, a Phase 3 study, has completed, sponsored by Johns Hopkins Bloomberg School of Public Health.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 59,666 participants
- Enrollment target
Study Summary
The purpose of this trial is to determine whether providing women with a weekly oral supplement of vitamin A, either preformed or as beta-carotene, at a dosage equivalent to a recommended intake from early pregnancy through three months postpartum, can reduce the risk of maternal mortality, fetal loss, or infant mortality.
Primary Outcome
Mortality evaluated on intent-to-treat basis
Interventions
- DIETARY_SUPPLEMENT Vitamin A or Beta-Carotene Supplements
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 59,666 participants |
| Start Date | 2001-08 |
| Est. Completion | 2008-03 |
| Phase | Phase 3 |
What the finished NCT00198822 record still lists
NCT00198822 is an interventional study that assigns participants to a tested intervention. Its 59,666 participants enrollment target places it among the larger protocols in the corpus, above the 768-participant average among 15,282 other Phase 3 trials with a reported enrollment target (7669% higher).
The record links to 0 conditions, and to 1 intervention - of which Vitamin A or Beta-Carotene Supplements is the first listed.
NCT00198822 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00198822 about?
NCT00198822 is a clinical study titled "Impact of Maternal Vitamin A or Beta-Carotene Supplementation on Maternal and Infant Mortality in Bangladesh". The purpose of this trial is to determine whether providing women with a weekly oral supplement of vitamin A, either preformed or as beta-carotene, at a dosage equivalent to a recommended intake from early pregnancy through three months postpartum, can reduce the risk of maternal mortality, fetal lo...
What is the current status of trial NCT00198822?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 59,666 participants. The study started on 2001-08. Estimated completion is 2008-03.
What interventions are being tested in trial NCT00198822?
The interventions under investigation include: Vitamin A or Beta-Carotene Supplements (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT00198822?
This trial is sponsored by Johns Hopkins Bloomberg School of Public Health, which has 187 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00198822's enrollment target sits among peer trials
59,666 3rd of 2000 higher than 1,998 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00785525 · 60,000 participants · Phase 3
Filgrastim-Mobilized Stem Cells for Transplantation Using Unrelated Donors
- NCT01825499 · 60,000 participants
Vermont Oxford Network Very Low Birth Weight Database
- NCT02850588 · 60,000 participants
SVS VQI TransCarotid Revascularization Surveillance Project
- NCT03752840 · 60,200 participants · NA
Village-Integrated Eye Worker Trial II
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia